Project
Participants
- Partners
- Associated Collaborators
Why EU-PEARL?
News
- News
- Events
- Blogs
RESOURCES
Contact
twitter
linkedin

Project
Participants
- Partners
- Associated Collaborators
Why EU-PEARL?
News
- News
- Events
- Blogs
RESOURCES
Contact
twitter
linkedin

Glossary

AJAX progress indicator

c
Clinical trial design
Clinical trial
i
Integrated Research Platform (IRP)
m
Master Protocol
p
Platform trials

Related Terms:

Term: Clinical trial design
Term: Clinical trial
Term: Integrated Research Platform (IRP)
Term: Master Protocol
Term: Platform trials

Acknowledgement

“EU-PEARL has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853966-2. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA”.

About IMI

The Innovative Medicines Initiative is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA). It is working to improve health by speeding up the development of the next generation of medicines, particularly in areas where there is an unmet medical or social need. It works by facilitating collaboration between the key players involved in health research, including universities, research centres, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is the world’s biggest public-private partnership (PPP) in the life sciences.

Legal notice | Privacy policy

Follow Us

Contact

info@eu-pearl.eu

© Copyright 2020 EU-PEARL | All Rights Reserved